The European Parliament's Committee on Environment, Public Health and Food Safety (ENVI) adopted a Pharmaceutical Strategy.
The European Parliament's Committee on Environment, Public Health and Food Safety (ENVI) meetings held on 11-12 October, during which the own initiative report (INI) on a Pharmaceutical Strategy for Europe was adopted. After weeks of negotiations, the MEPs agreed on 35 compromise amendments (originally, 723 amendments were published).
The concerning amendments are:
On 25 November 2020, the Commission published a Communication on a Pharmaceutical Strategy for Europe, a key tool to ensure that EU’s pharmaceutical policy continues to serve public health. Its goal is to give the EU's pharmaceutical policy a long-term vision: to ensure it is crisis-resilient and sustainable, and to reinforce EU's position as a global leader while ensuring access to affordable medicines for patients.